Boill Healthcare Holdings Ltd
Company Profile
Business description
Boill Healthcare Holdings Ltd is an investment holding company. Along with its subsidiaries, it operates in the property development segment, which includes the sale of properties, sales of construction materials, and the provision of property management services. The Group generates maximum revenue from the sales of properties. Additionally, it is focused on developing its business in the healthcare and leisure segment through the distribution of herbal tea, grain-related drinks, huangjiu and other Chinese liquor products, and other fast moving consumable goods. Geographically, the Group generates all of its revenue from the People's Republic of China (PRC).
Contact
167-169 Hennessy Road
15th Floor, Toi Shan Association Building
Wan Chai
Hong Kong
HKGSector
Real Estate
Stock type
Cyclical
Industry
Real Estate - Development
Fiscal Year End
31 March 2026
Employees
27
Stocks News & Analysis
stocks
ASX energy producers: Energy prices rise sharply as global tensions flare, but long-term view unchanged
stocks
ASX retail share remains cheap despite weaker earnings
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,712.80 | 44.30 | 0.51% |
| CAC 40 | 7,701.95 | 67.36 | -0.87% |
| DAX 40 | 22,300.75 | 312.22 | -1.38% |
| Dow JONES (US) | 45,165.80 | 794.31 | -1.73% |
| FTSE 100 | 9,967.35 | 4.82 | -0.05% |
| HKSE | 24,951.88 | 95.45 | 0.38% |
| NASDAQ | 20,948.36 | 459.72 | -2.15% |
| Nikkei 225 | 53,373.07 | 230.58 | -0.43% |
| NZX 50 Index | 12,935.39 | 41.60 | -0.32% |
| S&P 500 | 6,370.69 | 106.47 | -1.64% |
| S&P/ASX 200 | 8,516.30 | 44.70 | 0.53% |
| SSE Composite Index | 3,913.72 | 24.64 | 0.63% |